Monitoring Requirements for Hyperlipidaemia Treatments

Tests required for patients on lipid-lowering drugs.

Check which tests are needed for your patients on lipid-lowering drugs with the MIMS guide to monitoring requirements for hyperlipidaemia treatments.

This quick-reference table summarises the types and frequency of testing recommended for the following drug classes:

  • Bile acid sequestrants (colesevelam, colestipol, colestyramine)
  • Cholesterol absorption inhibitors (ezetimibe, ezetimibe/simvastatin)
  • Fibrates (bezafibrate, ciprofibrate, fenofibrate, gemfibrozil)
  • Fibrates/statins (fenofibrate/simvastatin)
  • Acipimox (Olbetam)
  • Omega-3 (Omacor, Teromeg)
  • PCSK9 inhibitors (alirocumab, evolocumab)
  • Statins (atorvastatin, fluvastatin, pravastatin, rosuvastatin, simvastatin)

Recommended tests include creatine kinase levels, liver and renal function, and vitamin levels.

Drug names link through to the full MIMS entries for more detailed prescribing information on each branded or generic product.

Information is summarised from manufacturers' Summaries of Product Characteristics (SPCs), available at

Go to the MIMS hyperlipidaemia table

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in